Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retraining of the Amygdala and Insula for the Treatment of Persistent Covid

NCT05956405 is registered in ClinicalTrials.gov with Hospital Miguel Servet as lead sponsor.

NCT NCT05956405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05956405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retraining of the Amygdala and Insula for the Treatment of Persistent Covid
Lead sponsor
Hospital Miguel Servet
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2023
Completion date
March 31, 2024
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mental health wellness